Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 9/20 | 1.00 |
| ▸ | HDAC8 | Q9BY41 | 7/20 | 1.00 |
| ▸ | HDAC2 | Q92769 | 7/20 | 1.00 |
| ▸ | HDAC11 | Q96DB2 | 6/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 1.00 |
| ▸ | HDAC4 | P56524 | 5/20 | 1.00 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 1.00 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 1.00 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 1.00 |
| ▸ | HDAC3 | O15379 | 5/20 | 1.00 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 0.76 |
| ▸ | LMNA | P02545 | 1/20 | 0.76 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | BRD4 | O60885 | 1/20 | 0.67 |
| ▸ | NCOR1 | O75376 | 1/20 | 0.67 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.67 |
| ▸ | EGFR | P00533 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5956924 | 1.00 | HDAC1 (1.00) | HDAC1HDAC8HDAC2HDAC11HDAC6 | |
| Pyroxamide SCHEMBL30184775 | 1.00 | HDAC1 (1.00) | HDAC1HDAC8HDAC2HDAC11HDAC6 | |
| SCHEMBL15480449 | 0.94 | HDAC3 (0.88) | HDAC1HDAC8HDAC2HDAC11HDAC6 | |
| SCHEMBL8277953 | 0.88 | HDAC3 (0.78) | HDAC1HDAC8HDAC2HDAC11HDAC6 | |
| SCHEMBL13477810 | 0.88 | LMNA (0.81) | HDAC1HDAC8HDAC2HDAC11HDAC6 | |
| SCHEMBL823590 | 0.87 | HDAC3 (0.76) | HDAC1HDAC8HDAC2HDAC11HDAC6 | |
| SCHEMBL16596336 | 0.87 | LMNA (1.00) | HDAC1HDAC8HDAC2HDAC11HDAC6 | |
| SCHEMBL823570 | 0.87 | LMNA (1.00) | HDAC1HDAC8HDAC2HDAC11HDAC6 | |
| SCHEMBL30444393 | 0.87 | LMNA (1.00) | HDAC1HDAC8HDAC2HDAC11HDAC6 | |
| SCHEMBL14415898 | 0.87 | LMNA (1.00) | HDAC1HDAC8HDAC2HDAC11HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2987 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107052-A1 | COMBINATION TREATMENTS USING EPIGENETIC INHIBITION AND SYNGRI-MEDIATED FRATAXIN EXPRESSION | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) | 2026-05-21 | — | — | WO | claimed |
| US-20260125650-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES | TRAILHEAD BIOSYSTEMS INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4691479-A2 | GENERATION OF HUMAN PLURIPOTENT STEM CELL DERIVED FUNCTIONAL BETA CELLS SHOWING A GLUCOSE-DEPENDENT MITOCHONDRIAL RESPIRATION AND TWO-PHASE INSULIN SECRETION RESPONSE | Janssen Biotech, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260007676-A1 | HDAC INHIBITORS FOR USE WITH NK CELL BASED THERAPIES | VIRACTA THERAPEUTICS INC (US) | 2026-01-08 | — | — | US | claimed |
| EP-4448107-B1 | DRUG DELIVERY SYSTEMS BASED ON ENDOPEROXIDES USEFUL IN DIAGNOSIS AND THERAPY, AND METHODS THEREOF | FACULDADE DE FARMACIA DA UNIV DE LISBOA (PT) | 2025-11-05 | — | — | EP | claimed |
| EP-4640714-A2 | METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST | PML Screening, LLC (US) | 2025-10-29 | — | — | EP | claimed |
| EP-4194548-B1 | GENERATION OF HUMAN PLURIPOTENT STEM CELL DERIVED FUNCTIONAL BETA CELLS SHOWING A GLUCOSE-DEPENDENT MITOCHONDRIAL RESPIRATION AND TWO-PHASE INSULIN SECRETION RESPONSE | JANSSEN BIOTECH INC (US) | 2025-10-22 | — | — | EP | claimed |
| CN-120189514-A | Use of HDAC inhibitors in the treatment of liver cancer | 浙江大学绍兴研究院 | 2025-06-24 | — | — | CN | claimed |
| US-20250161243-A1 | MEF2 TRANSCRIPTIONAL ACTIVATORS TO TREAT NEUROLOGIC CONDITIONS | THE SCRIPPS RESEARCH INSTITUTE | 2025-05-22 | — | — | US | claimed |
| WO-2025106604-A1 | COMPOSITIONS AND METHODS RELATING TO ANTIVIRAL THERAPEUTICS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2025-05-22 | — | — | WO | claimed |
| US-20040018968-A1 | Use of histone deacetylase inhibitors in combination with radiation for the treatment of cancer | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-01-29 | — | — | US | claimed |
| WO-2004009771-A2 | STENTS CAPABLE OF CONTROLLABLY RELEASING HISTONE DEACETYLASE INHIBITORS | ADVANCED STENT TECHNOLOGIES, INC. (US) | 2004-01-29 | — | — | WO | claimed |
| WO-2003088954-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2003-10-30 | — | — | WO | claimed |
| WO-2003083067-A2 | HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF MULTIPLE SCLEROSIS, AMYOTROPHIC LATERAL SCLEROSIS AND ALZHEIMER'S DISEASE | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2003-10-09 | — | — | WO | claimed |
| WO-2003075839-A2 | METHODS OF INDUCING TERMINAL DIFFERENTIATION | ATON PHARMA, INC. (US) | 2003-09-18 | — | — | WO | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| US-20030144340-A1 | Inhibition of histone deacetylase as a treatment for cardiac hypertrophy | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2003-07-31 | — | — | US | claimed |
| EP-1297851-A1 | Inhibition of histone deacetylase as a treatment for cardiac hypertrophy | Board of Regents, The University of Texas System (US) | 2003-04-02 | — | — | EP | claimed |
| WO-2002090534-A1 | METHOD FOR TREATING NEURODEGENERATIVE, PSYCHIATRIC AND OTHER DISORDERS WITH DEACETYLASE INHIBITORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2002-11-14 | — | — | WO | claimed |
| WO-2002085400-A1 | COMPOSITIONS AND METHODS FOR REESTABLISHING GENE TRANSCRIPTION THROUGH INHIBITION OF DNA METHYLATION AND HISTONE DEACETYLASE | SUPERGEN, INC. (US) | 2002-10-31 | — | — | WO | claimed |